SERUM ANTIBODY RESPONSES FOLLOWING ANAL AND PENILE INFECTION WITH HUMAN PAPILLOMAVIRUS IN TEENAGE MEN WHO HAVE SEX WITH MEN
H Zou, S Tabrizi, A Grulich, J Hocking, S Garland, C Bradshaw, C Fairley, M Chen
Sexually Transmitted Infections | BMJ PUBLISHING GROUP | Published : 2015
Awarded by Australian Research Council
This investigator initiated study was funded by Merck. Merck had no input into the design, analysis or reporting of the study. CKF has received honoraria from CSL Biotherapies and Merck and research funding from CSL Biotherapies. CKF owns shares in CSL Biotherapies the manufacturer for Gardasil. JSH has received an honorarium from CSL Biotherapies and is an investigator on an Australian Research Council funded project (LP0883831) that includes CSL Biotherapies as a research partner. AEG has received honoraria and untied research funding from CSL biotherapies, and has received honoraria from Merck. SMG has received advisory board fees and grant support from CSL and GlaxoSmithKline, and lecture fees from Merck, GSK and Sanofi Pasteur; in addition, she has received funding through her institution to conduct HPV vaccine studies for MSD and GSK. SMG is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV. None of this relates to this specific work. MYC reported his institution received a grant from Merck Sharp Dohme that supported the conduct of the study. MGL receives grants from Bristol Myer Squibb, Gilead, GlaxoSmithKline, Janssen-Cilag, Merck, Pfizer and Roche which are not related to this project. All other authors have no conflicts of interest.